News Summary: New Alzheimer's studies offer hope

Associated Press

ALZHEIMER'S RESEARCH: Scientists at drugmakers including Merck, Eli Lilly and Roche are starting a new round of studies of potential drugs to treat or perhaps even prevent Alzheimer's disease.

HOPE ON HORIZON: The Alzheimer's Association's top scientist says if the studies pan out, a medicine to slow or even stop progression of the mind-robbing disease could be ready in three to five years.

DESPERATELY NEEDED: As the U.S. population ages, the number of Alzheimer's patients is expected to jump from 5.4 million now to 16 million by 2050, when care costs could hit $1.1 trillion.

Sorry you didn't like this comment. Please provide a reason below.

Are you sure?
Rating failed. Try again.
Request failed. Try again.
We will promote constructive and witty comments to the top, so everyone sees them!
Sorry, we can’t load comments right now. Try again.

    Recommended for You